Artwork

Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Quest to Save American-Made Antibiotics

19:41
 
Share
 

Manage episode 430748249 series 3208963
Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

USAntibiotics's plant in Tennessee is one of the last plants in the United States that makes amoxicillin, the crucial antibiotic that has been in shortage in some forms since 2022. But the plant isn’t breaking even, financially. WSJ’s Liz Essley Whyte reports on why it is so hard for American-made generic drugs manufacturers to survive.

Further Listening:

- Will Florida’s Plan to Get Cheap Drugs From Canada Work?

- Trillion Dollar Shot

Further Reading:

- Drug Shortages in America Reach a Record High

- Drug Shortages Trigger FTC Probe

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1263 episodes

Artwork

The Quest to Save American-Made Antibiotics

The Journal.

1,481 subscribers

published

iconShare
 
Manage episode 430748249 series 3208963
Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

USAntibiotics's plant in Tennessee is one of the last plants in the United States that makes amoxicillin, the crucial antibiotic that has been in shortage in some forms since 2022. But the plant isn’t breaking even, financially. WSJ’s Liz Essley Whyte reports on why it is so hard for American-made generic drugs manufacturers to survive.

Further Listening:

- Will Florida’s Plan to Get Cheap Drugs From Canada Work?

- Trillion Dollar Shot

Further Reading:

- Drug Shortages in America Reach a Record High

- Drug Shortages Trigger FTC Probe

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1263 episodes

Tất cả các tập

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide